RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @iceman_ex: Vive la #FOAMed https://t.co/DmfRUZffoS
Does the ROSE trial disprove anything? As I read things, we have two fairly well done trials, one showing 👍 for NMBs, one showing 🤷♂️.
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @iceman_ex: Vive la #FOAMed https://t.co/DmfRUZffoS
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
@PulmCrit @Emnerd https://t.co/OK9PnSN2bv. Is the problem in the high PEEP strategy rather than the muscle relaxant? Not all ARDS pts need high PEEP.
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @iceman_ex: Vive la #FOAMed https://t.co/DmfRUZffoS
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @iceman_ex: Vive la #FOAMed https://t.co/DmfRUZffoS
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
Vive la #FOAMed
Oh dear! This is not looking good!
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
Whoops!
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline published yesterday: https://t.co/gedEgrRjde ROSE trial *disproving* it: https://t.co/EIZPUb8lp7 @emnerd explains ACURASYS: https:
RT @AACNme: Early continuous #neuromuscular blockade for #patients with moderate-to-severe ARDS doesn't improve mortality compared to using…
RT @AACNme: Early continuous #neuromuscular blockade for #patients with moderate-to-severe ARDS doesn't improve mortality compared to using…
Según concluye un estudio, el bloqueo neuromuscular temprano en pacientes con SDRA moderado a grave no mejora la mortalidad en comparación con una sedación más ligera. Discute los resultados con tu equipo. Sigue leyendo: https://t.co/OR3ND8hJbB a través de
RT @AACNme: Early continuous #neuromuscular blockade for #patients with moderate-to-severe ARDS doesn't improve mortality compared to using…
RT @AACNme: Early continuous #neuromuscular blockade for #patients with moderate-to-severe ARDS doesn't improve mortality compared to using…
Early continuous #neuromuscular blockade for #patients with moderate-to-severe ARDS doesn't improve mortality compared to using lighter sedation targets, a study concludes. Discuss the results with your team. Keep Reading: https://t.co/KOEsRd97o0 via @NEJM
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS). See the results of the new trial: https://t.co/NuuvVqJNh4 #AT
Dream trial would be proning without paralytics compared to standard of care https://t.co/hgWZ4AdodU
RT @CCJournalClub: Hi #medtwitter #FOAMcc #FOAMed! Join us for our 2nd tweet meet on May 26 9 PM central time & May 27 9 PM IST to discuss…
RT @UNMC_PCCM: What have you been reading lately? These were the articles discussed at our recent reading roundtable: Early Neuromuscular…
What have you been reading lately? These were the articles discussed at our recent reading roundtable: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/a4bA9fFVPI And Role of Atomoxetine and Oxybutynin in OSA.
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
Early neuromuscular blockade in #ARDS: https://t.co/kcGO5Tw781
RT @JHPICUFellows: 👏👏👏 to @DrTracieLin!! https://t.co/JB8MvlQG4F
RT @PravinPICU: Neat critical appraisal of the Rose Trial https://t.co/Gx51s62vjy
Neat critical appraisal of the Rose Trial
RT @SapnaKmd: So one of our @JHPICUFellows gave a Sentinel Article review for journal club on the recently published ROSE Trial in @NEJM an…
RT @SapnaKmd: So one of our @JHPICUFellows gave a Sentinel Article review for journal club on the recently published ROSE Trial in @NEJM an…
RT @WhistlingDixie4: Small summary of the recently published #ROSE study - early NMB in moderate to severe ARDs ...is it as important as we…
Flip-flop again: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/aI6WD5CFrc
RT @NEJM: Original Article: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome https://t.co/lcLOUi9RXe Editorial: Ear…
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
RT @strachanjamie: This is great I'm sure it was an awesome journal club presentation - thanks for sharing! My Q for @ffolliet is; define…
This is great I'm sure it was an awesome journal club presentation - thanks for sharing! My Q for @ffolliet is; define *good* for a JC presentation. The time-honoured "slidument" works -or does it? (@ChadwickRespICU have a butchers at this before your
RT @SapnaKmd: So one of our @JHPICUFellows gave a Sentinel Article review for journal club on the recently published ROSE Trial in @NEJM an…
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
RT @dr_mark_russell: Excellent journal club presentation of #ROSEtrial. Reminds me of journal club run by @harrykchris for @PICU_BCH #PedsI…
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
@gsmartinmd And the #ROSEtrial paper in @NEJM accompanied by an editorial from *another* @SummitCritCare plenary speaker, #JesusVillar https://t.co/D0ZktMa8cU https://t.co/7OemMkdEAK
RT @AnesthRea: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome #NEJM https://t.co/7Njhpw3cED
👏👏👏 to @DrTracieLin!!
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
Severe ARDS is very pathologically diverse disease. ‘Paralytics for all’ is not the answer but paralytics still hold a place in patients with vent asynchrony and patients to assist with plateau/ peak pressures.
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
RT @NEJM: The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade…
The PETAL trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS). See the results of the new trial: https://t.co/lcLOUi9RXe
RT @SapnaKmd: So one of our @JHPICUFellows gave a Sentinel Article review for journal club on the recently published ROSE Trial in @NEJM an…
RT @dr_mark_russell: Excellent journal club presentation of #ROSEtrial. Reminds me of journal club run by @harrykchris for @PICU_BCH #PedsI…
RT @dr_mark_russell: Excellent journal club presentation of #ROSEtrial. Reminds me of journal club run by @harrykchris for @PICU_BCH #PedsI…
Excellent journal club presentation of #ROSEtrial. Reminds me of journal club run by @harrykchris for @PICU_BCH #PedsICU
RT @AkshaySharmaMD: Excellent slides and even more impressive #mentorship 👇🏽 thank you @SapnaKmd and @DrTracieLin . I hope more mentors le…
RT @AkshaySharmaMD: Excellent slides and even more impressive #mentorship 👇🏽 thank you @SapnaKmd and @DrTracieLin . I hope more mentors le…
Excellent slides and even more impressive #mentorship 👇🏽 thank you @SapnaKmd and @DrTracieLin . I hope more mentors learn from this and help push their mentees into the academic world as well as #twitterverse 👏🏽 #MedEd #MedTwitter #SoMeDocs #PHOdocs
RT @SapnaKmd: So one of our @JHPICUFellows gave a Sentinel Article review for journal club on the recently published ROSE Trial in @NEJM an…
RT @SapnaKmd: So one of our @JHPICUFellows gave a Sentinel Article review for journal club on the recently published ROSE Trial in @NEJM an…
RT @SapnaKmd: So one of our @JHPICUFellows gave a Sentinel Article review for journal club on the recently published ROSE Trial in @NEJM an…
So one of our @JHPICUFellows gave a Sentinel Article review for journal club on the recently published ROSE Trial in @NEJM and it was so well done I asked her if she would share it publicly. Thanks @DrTracieLin ! https://t.co/LxX9l4FRrk ROSE Paper: https
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome #NEJM https://t.co/7Njhpw3cED